Filing Details
MYRIAD GENETICS INC (NASDAQ:MYGN) filed a Form 8-K with the Securities and Exchange Commission on October 09, 2026, disclosing a material event.
8k filedNASDAQ:MYGN
MYRIAD GENETICS INC (MYGN) Reports Material Event to SEC
MYRIAD GENETICS INC (NASDAQ:MYGN) filed a Form 8-K with the Securities and Exchange Commission on October 09, 2026, disclosing a material event.
At publication ·
What changed
MYRIAD GENETICS INC (NASDAQ:MYGN) · 8k filed
- Form
- 8-K
At a glance
Key takeaways
- Myriad Genetics filed a Form 8-K with the SEC on October 9, 2026, disclosing a material event requiring shareholder notification.
- The company's stock trades at $4.20 with a market capitalization of $680.9 million.
- Material events reported on Form 8-K typically include leadership changes, acquisitions, asset sales, or financial guidance modifications.
Market Context
MYRIAD GENETICS INC's stock currently trades at $4.20 with a market capitalization of $680.9M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for MYRIAD GENETICS INC's stock.
All SEC filings for MYRIAD GENETICS INC are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View MYGN Stock Page
Frequently Asked Questions
Where can I read MYGN's SEC filings?
Browse all filings on our MYGN SEC filings page.
What types of SEC filings does MYRIAD GENETICS INC file?
Public companies like MYRIAD GENETICS INC file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.